{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T11:41:08Z","timestamp":1743075668055,"version":"3.40.3"},"reference-count":16,"publisher":"BMJ","issue":"e2","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Support Palliat Care"],"accepted":{"date-parts":[[2023,12,21]]},"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:p>Methemoglobinemia, due to the oxidation of iron from ferrous to ferric form in the haemoglobin molecule, results in decreased oxygen delivery to the tissues. Phenazopyridine, a commonly used medication for urinary symptoms, is a rare cause of methemoglobinemia. We report an elderly woman with advanced vaginal cancer, who developed methemoglobinemia following the use of phenazopyridine at a dose of 200 mg three times a day for 14 days. She presented with dyspnoea without cyanosis, oxygen saturation of 70%, methemoglobin concentration of 32.2% in arterial blood gas analysis and haemoglobin of 5 g\/dL. This condition was identified and treated with methylene blue and oxygen support, which resulted in complete recovery in two days. Though rare, this highlights the importance of ascertaining reversible causes of symptoms, even in palliative care settings. Medications as an aetiology of symptoms should be considered even if they were used on a long-term basis.<\/jats:p>","DOI":"10.1136\/spcare-2023-004692","type":"journal-article","created":{"date-parts":[[2024,1,10]],"date-time":"2024-01-10T05:09:59Z","timestamp":1704863399000},"page":"e1792-e1794","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Rare cause of dyspnoea: phenazopyridine-induced methemoglobinemia"],"prefix":"10.1136","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-2596-5370","authenticated-orcid":false,"given":"Jewell","family":"Joseph","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7200-4452","authenticated-orcid":false,"given":"Jenifer Jeba","family":"Sundararaj","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Shekinah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selvaguru","family":"Kamalakannan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2024,1,2]]},"reference":[{"key":"2025032703260711000_14.e2.e1792.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpainsymman.2020.04.027"},{"key":"2025032703260711000_14.e2.e1792.2","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3390\/clinpract12060089","article-title":"A case of severe hypoxia caused by phenazopyridine-induced methemoglobinemia: a near fatal event from over-the-counter medication use","volume":"12","author":"Kc","year":"2022","journal-title":"Clin Pract"},{"key":"2025032703260711000_14.e2.e1792.3","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1152\/ajplegacy.1942.137.1.56","article-title":"The effect of methemoglobin on the equilibrium between oxygen and hemoglobin","volume":"137","author":"Darling","year":"1942","journal-title":"Am J Physiol"},{"key":"2025032703260711000_14.e2.e1792.4","doi-asserted-by":"publisher","DOI":"10.1097\/SMJ.0b013e318232139f"},{"key":"2025032703260711000_14.e2.e1792.5","doi-asserted-by":"publisher","DOI":"10.1016\/S0196-0644(99)70167-8"},{"key":"2025032703260711000_14.e2.e1792.6","doi-asserted-by":"crossref","unstructured":"Daly JS , Hultquist DE , Rucknagel DL . Phenazopyridine induced Methaemoglobinaemia associated with decreased activity of Erythrocyte cytochrome B5 reductase. Journal of Medical Genetics 1983.","DOI":"10.1136\/jmg.20.4.307"},{"key":"2025032703260711000_14.e2.e1792.7","doi-asserted-by":"publisher","DOI":"10.4065\/83.7.744"},{"key":"2025032703260711000_14.e2.e1792.8","doi-asserted-by":"crossref","DOI":"10.1097\/MAJ.0b013e3181df9369","article-title":"Chocolate-colored blood with normal artery oxygen: Methemoglobinemia related to Phenazopyridine","volume":"341","author":"Yu","year":"2011","journal-title":"Am J Med Sci"},{"key":"2025032703260711000_14.e2.e1792.9","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2012-006756","article-title":"Acquired Methaemoglobinaemia related to Phenazopyridine ingestion","volume":"2012","author":"Shahani","year":"2012","journal-title":"BMJ Case Rep"},{"key":"2025032703260711000_14.e2.e1792.10","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.amjmed.2013.02.021","article-title":"Unexplained hypoxia in a woman presenting with acute on chronic abdominal pain","volume":"126","author":"Shatila","year":"2013","journal-title":"Am J Med"},{"key":"2025032703260711000_14.e2.e1792.11","doi-asserted-by":"crossref","first-page":"627","DOI":"10.5811\/westjem.2016.6.30504","article-title":"A rare but important clinical presentation of induced Methemoglobinemia","volume":"17","author":"Banimahd","year":"2016","journal-title":"West J Emerg Med"},{"key":"2025032703260711000_14.e2.e1792.12","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12245-018-0208-5","article-title":"Acquired Methemoglobinemia from Phenazopyridine use","volume":"11","author":"Murphy","year":"2018","journal-title":"Int J Emerg Med"},{"key":"2025032703260711000_14.e2.e1792.13","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2018-227538","article-title":"Methemoglobinaemia with chronic Phenazopyridine ingestion","volume":"12","author":"Agrawal","year":"2019","journal-title":"BMJ Case Rep"},{"key":"2025032703260711000_14.e2.e1792.14","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.urology.2019.03.017","article-title":"Perioperative hypoxia secondary to Phenazopyridine-induced Methemoglobinemia in an adolescent patient without renal insufficiency or overdose: an unusual case","volume":"130","author":"Shah","year":"2019","journal-title":"Urology"},{"key":"2025032703260711000_14.e2.e1792.15","first-page":"003191","article-title":"Phenazopyridine-induced Methaemoglobinaemia the aftermath of Dysuria treatment","volume":"9","author":"Hamza","year":"2022","journal-title":"Eur J Case Rep Intern Med"},{"key":"2025032703260711000_14.e2.e1792.16","article-title":"Phenazopyridine-induced Methemoglobinemia: A case report","volume":"15","author":"Koch","year":"2023","journal-title":"Cureus"}],"container-title":["BMJ Supportive &amp; Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/spcare-2023-004692","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T11:03:55Z","timestamp":1743073435000},"score":1,"resource":{"primary":{"URL":"https:\/\/spcare.bmj.com\/lookup\/doi\/10.1136\/spcare-2023-004692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,2]]},"references-count":16,"journal-issue":{"issue":"e2","published-online":{"date-parts":[[2024,11,15]]},"published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.1136\/spcare-2023-004692"],"URL":"https:\/\/doi.org\/10.1136\/spcare-2023-004692","relation":{},"ISSN":["2045-435X","2045-4368"],"issn-type":[{"type":"print","value":"2045-435X"},{"type":"electronic","value":"2045-4368"}],"subject":[],"published":{"date-parts":[[2024,1,2]]}}}